Literature DB >> 15754073

Economic evidence in migraine and other headaches: a review.

Jenny Berg1.   

Abstract

Entities:  

Mesh：

Year:  2004        PMID： 15754073     DOI： 10.1007/s10198-005-0288-z

Source DB:  PubMed          Journal:  Eur J Health Econ        ISSN： 1618-7598


× No keyword cloud information.
  9 in total

1.  Cost of healthcare for patients with migraine in five European countries: results from the International Burden of Migraine Study (IBMS).

Authors:  L M Bloudek; M Stokes; D C Buse; T K Wilcox; R B Lipton; P J Goadsby; S F Varon; A M Blumenfeld; Z Katsarava; J Pascual; M Lanteri-Minet; P Cortelli; P Martelletti
Journal:  J Headache Pain       Date:  2012-05-29       Impact factor: 7.277

2.  Higher burden of migraine compared to other neurological conditions: results from a cross-sectional study.

Authors:  Matilde Leonardi
Journal:  Neurol Sci       Date:  2014-05       Impact factor: 3.307

3.  Cost of disorders of the brain in Italy.

Authors:  Maura Pugliatti; Patrik Sobocki; Ettore Beghi; Stefano Pini; Giovanni B Cassano; A Carlo Altamura; Sara Pozzoli; Giulio Rosati
Journal:  Neurol Sci       Date:  2008-05-16       Impact factor: 3.307

Review 4.  Impact of headache in Europe: a review for the Eurolight project.

Authors:  Lars Jacob Stovner; Colette Andrée
Journal:  J Headache Pain       Date:  2008-04-17       Impact factor: 7.277

5.  Service use and costs for people with headache: a UK primary care study.

Authors:  Paul McCrone; Paul T Seed; Andrew J Dowson; Lucy V Clark; Laura H Goldstein; Myfanwy Morgan; Leone Ridsdale
Journal:  J Headache Pain       Date:  2011-07-09       Impact factor: 7.277

6.  Cost of Chronic and Episodic Migraine. A pilot study from a tertiary headache centre in northern Italy.

Authors:  E Berra; G Sances; R De Icco; M Avenali; M Berlangieri; I De Paoli; M Bolla; M Allena; N Ghiotto; E Guaschino; S Cristina; C Tassorelli; G Sandrini; G Nappi
Journal:  J Headache Pain       Date:  2015-05-27       Impact factor: 7.277

Review 7.  A systematic review of economic evaluations of pharmacological treatments for adults with chronic migraine.

Authors:  Saval Khanal; Martin Underwood; Seyran Naghdi; Anna Brown; Callum Duncan; Manjit Matharu; Hema Mistry
Journal:  J Headache Pain       Date:  2022-09-16       Impact factor: 8.588

8.  Prospective analysis of the use of OnabotulinumtoxinA (BOTOX) in the treatment of chronic migraine; real-life data in 254 patients from Hull, U.K.

Authors:  Modar Khalil; Hassan W Zafar; Victoria Quarshie; Fayyaz Ahmed
Journal:  J Headache Pain       Date:  2014-09-01       Impact factor: 7.277

9.  Productivity Losses Due to Migraine in Slovenia: An Analysis of Absenteeism and Presenteeism Costs Based on Administrative and Self-Reported Data.

Authors:  Aleša Lotrič Dolinar; Bojana Žvan; Petra Došenović Bonča
Journal:  Zdr Varst       Date:  2020-04-06
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.